Genovate Biotechnology Co Stock Current Valuation
| 4130 Stock | TWD 21.95 0.05 0.23% |
Valuation analysis of Genovate Biotechnology helps investors to measure Genovate Biotechnology's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Genovate Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of Genovate Biotechnology is based on 3 months time horizon. Increasing Genovate Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Genovate stock is determined by what a typical buyer is willing to pay for full or partial control of Genovate Biotechnology Co. Since Genovate Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genovate Stock. However, Genovate Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 21.95 | Real 22.16 | Hype 21.95 | Naive 21.96 |
The intrinsic value of Genovate Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Genovate Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Genovate Biotechnology Co helps investors to forecast how Genovate stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genovate Biotechnology more accurately as focusing exclusively on Genovate Biotechnology's fundamentals will not take into account other important factors: Genovate Biotechnology Co Company Current Valuation Analysis
Genovate Biotechnology's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Genovate Biotechnology Current Valuation | 3.16 B |
Most of Genovate Biotechnology's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genovate Biotechnology Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Genovate Biotechnology Co has a Current Valuation of 3.16 B. This is 77.97% lower than that of the Healthcare sector and 31.9% lower than that of the Biotechnology industry. The current valuation for all Taiwan stocks is 80.97% higher than that of the company.
Genovate Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genovate Biotechnology's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genovate Biotechnology could also be used in its relative valuation, which is a method of valuing Genovate Biotechnology by comparing valuation metrics of similar companies.Genovate Biotechnology is currently under evaluation in current valuation category among its peers.
Genovate Fundamentals
| Return On Equity | 0.0022 | |||
| Return On Asset | 0.0015 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 3.16 B | |||
| Shares Outstanding | 109.38 M | |||
| Shares Owned By Insiders | 3.95 % | |||
| Shares Owned By Institutions | 26.96 % | |||
| Price To Book | 2.62 X | |||
| Price To Sales | 9.42 X | |||
| Revenue | 434.25 M | |||
| Gross Profit | 149.75 M | |||
| EBITDA | 39.64 M | |||
| Net Income | 372 K | |||
| Book Value Per Share | 12.82 X | |||
| Cash Flow From Operations | (17.26 M) | |||
| Earnings Per Share | 0.03 X | |||
| Number Of Employees | 181 | |||
| Beta | 0.21 | |||
| Market Capitalization | 3.3 B | |||
| Total Asset | 1.52 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 1.52 B | |||
| Last Dividend Paid | 0.35 |
About Genovate Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genovate Biotechnology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genovate Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genovate Biotechnology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Genovate Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genovate Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovate Biotechnology will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Genovate Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genovate Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genovate Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genovate Biotechnology Co to buy it.
The correlation of Genovate Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genovate Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genovate Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genovate Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.